| Literature DB >> 30423075 |
Evert Bosdriesz1, Anirudh Prahallad1, Bertram Klinger2,3, Anja Sieber2,3, Astrid Bosma1, René Bernards1, Nils Blüthgen2,3,4, Lodewyk F A Wessels1,5.
Abstract
Motivation: Signal-transduction networks are often aberrated in cancer cells, and new anti-cancer drugs that specifically target oncogenes involved in signaling show great clinical promise. However, the effectiveness of such targeted treatments is often hampered by innate or acquired resistance due to feedbacks, crosstalks or network adaptations in response to drug treatment. A quantitative understanding of these signaling networks and how they differ between cells with different oncogenic mutations or between sensitive and resistant cells can help in addressing this problem.Entities:
Mesh:
Year: 2018 PMID: 30423075 PMCID: PMC6129277 DOI: 10.1093/bioinformatics/bty616
Source DB: PubMed Journal: Bioinformatics ISSN: 1367-4803 Impact factor: 6.937
Fig. 1.Schematic illustration of CNR. CNR requires perturbation data (log2-fold changes of node activity compared to a reference state) of one or multiple cell lines as input. Optionally, information on the network topology or edge signs can be included. Based on this data, an MIQP problem is formulated that aims to find a network model that fits the data the while penalizing the number of edges in the network and the number of quantitative differences between the cell lines. The output is a network quantification and identification of which edges differ between the cell lines. Edge-weights indicate how strongly a target node responds to a change in the activity in the source node
Fig. 2.Orton model simulation and CNR results. For all results presented here, 10% noise was added to the simulated data. (A) Network topology of the modules in the Orton model. (B) Receiver-operator-curves of network reconstructions using noisy data of the wild-type model, the BRAF model and both combined, with θ = 0. (C) Fitting error versus number of differing edges between cell lines indicate that most edges can be set to the same value without affecting model fit. (D) Network reconstructions of the wild-type and BRAF mutant model. Left: Network topology. Edges that differ between the model-reconstructions are highlighted. Green edges are positive, red ones negative. Right: Correlation between reconstructed and actual model parameters. (E) True (top) and False (bottom) positive rates of network reconstruction as function of the number of perturbations in the input data. (F) Spearman correlation between predicted and simulated model parameters (top) and response for perturbations that were not used in reconstructing the network (bottom)
Fig. 3.Perturbation experiments in PTPN11 WT, KO and BRAF inihibitor resistant cells. (A) Schematic of role of PTPN11 in signal transduction. (B) Overview of the cell-lines used. VACO432 cells are insensitive to BRAF inhibition, but can be sensitized by knocking out PTPN11. Prolonged culturing VACO432 PTPN11 KO cells in the presence of BRAF inhibitor gives rise to resistant VACO432 PTPN11 KO cells. (C) Results of the perturbation experiments. The color scale indicates log2-fold change relative to unstimulated, uninhibited controls
Fig. 4.Model reconstruction of sensitive and persister VACO432 cells. (A) Network reconstruction from perturbation data. (B) Overview of parameters that differ in many of the solutions. (C) Boxplots of selected parameters indicating that the differences are quantitatively similar in different solutions. (D) Hypothesis: Resistance is due to re-establishment of normal MAPK signaling. (E) Consistently, pERK is activated and GTP constitutively loaded with GTP